{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T04:18:33Z","timestamp":1786249113991,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.lpm.2013.01.057","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T18:03:16Z","timestamp":1366912996000},"page":"e217-e224","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Multifocal motor neuropathy"],"prefix":"10.1016","volume":"42","author":[{"given":"Raquel","family":"Guimar\u00e3es-Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"L\u00e9ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2013.01.057_bib0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000116045","article-title":"Motor neuropathy with proximal multifocal persistent block, fasciculations and myokyma. Evolution to tetraplegia","volume":"25","author":"Roth","year":"1986","journal-title":"Eur Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0010","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.36.9.1260","article-title":"Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome","volume":"36","author":"Chad","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410240113","article-title":"A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside","volume":"24","author":"Pestronk","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410300312","article-title":"Immunosuppressive treatment in multifocal motor neuropathy","volume":"30","author":"Feldman","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mus.20296","article-title":"Multifocal motor neuropathy: current concepts and controversies","volume":"31","author":"Nobile-Orazio","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.057_bib0030","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1212\/WNL.0b013e3181f0738e","article-title":"Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0035","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/01.wnl.0000277697.55288.d0","article-title":"Multifocal motor neuropathy: the diagnosis spectrum and response to treatment","volume":"69","author":"Slee","year":"2007","journal-title":"Neurology"},{"issue":"HS1","key":"10.1016\/j.lpm.2013.01.057_bib0040","first-page":"3S27","article-title":"Prise en charge des neuropathies motrices multifocales avec blocs de conduction en France en 2005","volume":"162","author":"L\u00e9ger","year":"2006","journal-title":"Rev Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0045","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/01.wnl.0000203346.25068.3f","article-title":"Childhood-onset multifocal motor neuropathy with conduction blocks","volume":"66","author":"Moroni","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1529-8027.2010.00290.x","volume":"15","author":"Van Schaik","year":"2010","journal-title":"J Periph Nervous System"},{"key":"10.1016\/j.lpm.2013.01.057_bib0055","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0755-4982(06)74669-3","article-title":"Neuropathie motrice multificale avec blocs de conduction persistants\u00a0: une neuropathie dysimmunitaire chronique","volume":"35","author":"L\u00e9ger","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2013.01.057_bib0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neurol.2008.10.018","article-title":"Multifocal motor neuropathy: a retrospective study of sensory nerve conduction velocities in long-term follow-up of 21 patients","volume":"165","author":"Lievens","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0065","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s00415-009-5217-0","article-title":"Do patients having a decrease in SNAP amplitude during the course of MMN present with a different condition?","volume":"256","author":"Delmont","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00415-010-5712-3","article-title":"Cold paresis in multifocal motor neuropathy","volume":"258","author":"Straver","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0075","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jocn.2011.12.030","article-title":"Cranial nerve involvement as presenting sign of multifocal motor neuropathy","volume":"19","author":"Galassi","year":"2012","journal-title":"J Clin Neurosc"},{"key":"10.1016\/j.lpm.2013.01.057_bib0080","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/01.wnl.0000234063.51897.20","article-title":"Multifocal motor neuropathy with and without conduction block. A single entity?","volume":"67","author":"Delmont","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0085","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mus.20434","article-title":"Magnetic stimulation using a triple-stimulation technique in patients with multifocal neuropathy without conduction block","volume":"32","author":"Attarian","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.057_bib0090","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mus.20742","article-title":"Triple-stimulation technique in multifocal neuropathy with conduction block","volume":"35","author":"Deroide","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.057_bib0095","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ana.410280206","article-title":"A computer simulation of conduction block: effects produced by actual conduction block versus interphase cancellation","volume":"28","author":"Rhee","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0100","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/brain\/awl197","article-title":"Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve","volume":"129","author":"Van Asseldonk","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.057_bib0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.54.1.26","article-title":"Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?","volume":"54","author":"Van den Berg-Vos","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0960-8966(00)00191-7","article-title":"79th ENMC International Workshop: multifocal motor neuropathy: 14\u201315 April 2000, Hilversum, The Netherlands","volume":"11","author":"Buchwald","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.lpm.2013.01.057_bib0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mus.10317","article-title":"Consensus criteria for the diagnosis of multifocal motor neuropathy","volume":"27","author":"Olney","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.057_bib0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000282734","article-title":"Multifocal motor neuropathy: update on clinical characteristics, pathophysiological concepts and therapeutic options","volume":"63","author":"Meuth","year":"2010","journal-title":"Eur Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0125","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/WNL.0b013e3181ff94c2","article-title":"Multifocal motor neuropathy. Association of anti-GM1 IgM antibodies with clinical features","volume":"75","author":"Cats","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0130","first-page":"6S16","article-title":"Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies","volume":"158","author":"Willison","year":"2001","journal-title":"Rev Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2009.11.012","article-title":"Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies","volume":"219","author":"Nobile-Orazio","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0140","article-title":"Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy","author":"Galban-Horcajo","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0145","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/jnnp.2010.239210","article-title":"Seeing the blocks: MRI of the brachial plexus in multifocal motor neuropathy","volume":"82","author":"Echaniz-Laguna","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.lpm.2013.01.057_bib0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.17925\/ENR.2012.07.02.124","article-title":"Clinical differential diagnosis of multifocal motor neuropathy","volume":"7","author":"L\u00e9ger","year":"2012","journal-title":"Eur Neurol Rev"},{"issue":"6","key":"10.1016\/j.lpm.2013.01.057_bib0155","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-011-6315-3","article-title":"Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members","volume":"259","author":"Cats","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0160","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/WNL.0b013e3181d3e2f6","article-title":"Increased frequency of HLA-DRB1*15 in patients with multifocal motor neuropathy","volume":"74","author":"Sutedja","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0165","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.50.5.1480","article-title":"Deterioration of multifocal motor neuropathy after plasma exchange","volume":"50","author":"Carpo","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.68.4.533","article-title":"Plasmapheresis in multifocal motor neuropathy: a case report","volume":"68","author":"Claus","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.057_bib0175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.57.7.778","article-title":"Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin","volume":"57","author":"Donaghy","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.057_bib0180","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1212\/WNL.48.4.1135","article-title":"Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy","volume":"48","author":"Van den Berg","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1196\/annals.1423.026","article-title":"Efficacy of intravenous immunoglobulin in multifocal motor neuropathy","volume":"1110","author":"L\u00e9ger","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lpm.2013.01.057_bib0190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1212\/WNL.44.3_Part_1.429","article-title":"Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study","volume":"44","author":"Azulay","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/jnnp.59.3.248","article-title":"Treatment of multifocal motor neuropathy with high-dose intravenous immunoglobulins: a double-blind, placebo-controlled study","volume":"59","author":"Van den Berg","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.057_bib0200","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1212\/WNL.55.9.1256","article-title":"Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study","volume":"55","author":"Federico","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/brain\/124.1.145","article-title":"Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study","volume":"124","author":"L\u00e9ger","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.057_bib0210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jneuroim.2010.08.023","article-title":"IVIg inhibits classical pathway activity and anti-GM1 IGM-mediated complement deposition in MMN","volume":"229","author":"Piepers","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2013.01.057_bib0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.2010.205856","article-title":"IVIg blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy","volume":"82","author":"Yuki","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.057_bib0220","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s10875-010-9408-3","article-title":"Intravenous immunoglobulin treatment in multifocal motor neuropathy","volume":"30","author":"Van der Pol","year":"2010","journal-title":"J Clin Immunol"},{"issue":"3","key":"10.1016\/j.lpm.2013.01.057_bib0225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s004150200013","article-title":"Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment","volume":"249","author":"Van den Berg-Vos","year":"2002","journal-title":"J Neurol"},{"issue":"Pt 8","key":"10.1016\/j.lpm.2013.01.057_bib0230","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awf193","article-title":"Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment","volume":"125","author":"Van den Berg-Vos","year":"2002","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.lpm.2013.01.057_bib0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1212\/01.WNL.0000110185.23464.A1","article-title":"How long is IVIg effective in multifocal motor neuropathy?","volume":"62","author":"Terenghi","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.lpm.2013.01.057_bib0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jnnp.2007.121756","article-title":"Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients","volume":"79","author":"L\u00e9ger","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.lpm.2013.01.057_bib0245","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/01.WNL.0000140497.85952.FA","article-title":"Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg","volume":"63","author":"Vucic","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.057_bib0250","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1212\/WNL.0b013e3181f735ce","article-title":"Long-term therapy with high-doses of subcutaneous immunoglobulin in multifocal motor neuropathy","volume":"75","author":"Harbo","year":"2010","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.lpm.2013.01.057_bib0255","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/brain\/awm144","article-title":"Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial","volume":"130","author":"Piepers","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.057_bib0260","first-page":"CD003217","article-title":"Immunosupressant and immunomodulatory treatments for multifocal motor neuropathy (review)","volume":"4","author":"Umapathi","year":"2012","journal-title":"Cochrane Libr"},{"issue":"2","key":"10.1016\/j.lpm.2013.01.057_bib0265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1529-8027.2011.00328.x","article-title":"An open label clinical trial of complement inhibition in multifocal motor neuropathy","volume":"16","author":"Fitzpatrick","year":"2011","journal-title":"J Peripher Nerv Syst"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T11:22:46Z","timestamp":1539688966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498213005113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0755498213005113"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.01.057","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}